5,5'-Dimethyl-2-phenyl-2'-(4-phenyl-1,3-thiazol-2-yl)-2H,2'H-[3,4'-bipyrazole]-3'-ol

Catalog No. :
ACAGLY309
CAS No. :
155299-83-5
Molecular Formula :
C23H19N5OS
Molecular Weight :
413.51

IUPAC Name:3',5-dimethyl-2-phenyl-1'-(4-phenylthiazol-2-yl)-1'H,2H-[3,4'-bipyrazol]-5'-ol

5,5'-Dimethyl-2-phenyl-2'-(4-phenyl-1,3-thiazol-2-yl)-2H,2'H-[3,4'-bipyrazole]-3'-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$566.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5,5'-Dimethyl-2-phenyl-2'-(4-phenyl-1,3-thiazol-2-yl)-2H,2'H-[3,4'-bipyrazole]-3'-ol
IUPAC Name3',5-dimethyl-2-phenyl-1'-(4-phenylthiazol-2-yl)-1'H,2H-[3,4'-bipyrazol]-5'-ol
MDL No.MFCD00141210
Molecular FormulaC23H19N5OS
Molecular Weight413.51
SMILESCC1=NN(C2=CC=CC=C2)C(C2=C(O)N(C3=NC(C4=CC=CC=C4)=CS3)N=C2C)=C1
InChI KeyOIRLBCUEDFJAEH-UHFFFAOYSA-N
Synonym3,3'-DIMETHYL-1-(4-PHENY-2-THIAZOLYL)-1'-PHENYL-5-HYDROXY[4,5']-BIPYRAZOL;5,5'-dimethyl-2-phenyl-2'-(4-phenyl-1,3-thiazol-2-yl)-2H,2'H-[3,4'-bipyrazole]-3'-ol;[4,5'-Bi-1H-pyrazol]-5-ol, 3,3'-dimethyl-1'-phenyl-1-(4-phenyl-2-thiazolyl)- (9CI);5,5'-Dimethyl-2-phenyl-2'-(4-phenylthiazol-2-yl)-1',2'-dihydro-2H,3'H-[3,4'-bipyrazol]-3'-one
CAS No.155299-83-5

Synthetic Route by SureRoute

1. ACAGLY309 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACAGLY309 route product structure diagram
    ACAGLY309155299-83-5
Inquiry

2. ACAGLY309 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAGLY309 route product structure diagram
    ACAGLY309155299-83-5
Inquiry

Comments (0)